The task of distributing a COVID-19 vaccine around the world has been likened to the mission to put a man on the moon.
By IATA’s estimate, it would take more than 8,000 Boeing 747 freighters to carry the 7.8 billion doses required for a single-shot immunisation of the global population.
Yet this striking lunar comparison is at once too optimistic and too pessimistic. The vast majority of the nearly 250 vaccine development programmes currently in progress around the globe are for two-shot inoculations. But, on the other hand, most informed industry groups predict that global distribution will be a longer sustained effort rather than one heavy simultaneous burst. According to a study by McKinsey, announcements from manufacturers indicate that global production capacity could turn out one billion doses by the end of this year and between eight and nine billion by the end of 2021.
Nevertheless, airfreight capacity is a headache. According to IATA, the global freighter fleet is pretty much maxed out. With scheduled belly capacity still severely curtailed by the virus, passenger aircraft on cargo missions are going to have a significant part to play in this effort.